TheraCell Announces First Surgical Use Of TheraFuze DBF® Fiber Bullets™ In An Interbody TLIF Cage
TheraCell Announces First Surgical Use Of TheraFuze DBF® Fiber Bullets™ In An Interbody TLIF Cage TheraCell completes first surgical case with the TheraFuze DBF® Fiber Bullets™ offering surgeons an improved solution for allograft delivery in MIS surgeries News provided by Share this article Share this article LOS ANGELES, Dec. 30, 2020 /PRNewswire/ -- TheraCell Inc., a leading allograft solution company, today announced that it has completed the first surgical case using its TheraFuze DBF® Fiber Bullets™. This unique DBF fiber form is designed for minimal access delivery into expa...
Source: prnewswire.com